Condition: Chronic Inflammatory Demyelinating Polyneuropathy · Sponsor: Sanofi
The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · contact-us@sanofi.com
Always discuss trial participation with your own doctor first.
| Alabama Neurology Associates- Site Number : 8400019 | Homewood, Alabama, United States | Recruiting |
| Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014 | Scottsdale, Arizona, United States | Recruiting |
| Keck School of Medicine of University of Southern California- Site Number : 8400002 | Los Angeles, California, United States | Recruiting |
| University of California Irvine Medical Center- Site Number : 8400007 | Orange, California, United States | Recruiting |
| IMMUNOe International Research Centers - Centennial- Site Number : 8400049 | Centennial, Colorado, United States | Recruiting |
| Yale University School of Medicine- Site Number : 8400018 | New Haven, Connecticut, United States | Recruiting |
| Nova Clinical Research - Bradenton- Site Number : 8400044 | Bradenton, Florida, United States | Recruiting |
| Design Neuroscience Center- Site Number : 8400053 | Miami Lakes, Florida, United States | Recruiting |
| AdventHealth Orlando- Site Number : 8400006 | Orlando, Florida, United States | Recruiting |
| AdventHealth Site Number : 8400006 | Orlando, Florida, United States | Recruiting |
| NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024 | Glenview, Illinois, United States | Recruiting |
| University of Kansas Medical Center- Site Number : 8400010 | Kansas City, Kansas, United States | Recruiting |
+ 117 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06290141